Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03663348 · ClinicalTrials.gov registry record
Registry of Patients With Takotsubo Syndrome
A clinical trial of Takotsubo Cardiomyopathy and Broken Heart Syndrome, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03663348: Recruiting study of Takotsubo Cardiomyopathy and Broken Heart Syndrome, sponsored by NYU Langone Health.
NCT03663348 is a study of Takotsubo Cardiomyopathy and Broken Heart Syndrome that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 500 participants, above the 363-participant average among 3 other Takotsubo Cardiomyopathy trials with a reported enrollment target (38% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03663348, a study of Takotsubo Cardiomyopathy and Broken Heart Syndrome, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Takotsubo syndrome is a condition which mimics acute myocardial infarction, and is diagnosed in 1.5% to 2.2% of patients referred to hospital with suspected acute coronary syndrome. It is also known as broken heart syndrome, takotsubo cardiomyopathy, stress cardiomyopathy and apical ballooning cardiomyopathy, among other names. The pathogenesis of this disorder is not well understood. Possible mechanisms include catecholamine excess, coronary artery spasm, microvascular dysfunction, among others. This is a multicenter, nation-wide, observational study of patients who were previously diagnosed with takotsubo syndrome. The investigators aim to use this registry to help plan and carry out further studies and to improve understanding of the pathophysiologic mechanisms of this syndrome. In addition participants will be followed for events, and to monitor quality of life and stress.
Primary Outcome
Medical record review and patient report of repeat takotsubo event, MI, heart failure, unstable angina, chest pain ER visit, cardiovascular death, stroke
Conditions Studied
Study Locations (1)
New York
- NYU School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2009-09-11 |
| Est. Completion | 2029-08-01 |
What NCT03663348 shows while recruiting
NCT03663348 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 363-participant average among 3 other Takotsubo Cardiomyopathy trials with a reported enrollment target (38% higher).
The record links to 2 conditions, with Takotsubo Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.
NCT03663348 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03663348 about?
NCT03663348 is a clinical study titled "Registry of Patients With Takotsubo Syndrome". Takotsubo syndrome is a condition which mimics acute myocardial infarction, and is diagnosed in 1.5% to 2.2% of patients referred to hospital with suspected acute coronary syndrome. It is also known as broken heart syndrome, takotsubo cardiomyopathy, stress cardiomyopathy and apical ballooning cardi...
What is the current status of trial NCT03663348?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2009-09-11. Estimated completion is 2029-08-01.
What conditions does trial NCT03663348 study?
This clinical trial studies the following conditions: Takotsubo Cardiomyopathy, Broken Heart Syndrome.
Who is sponsoring clinical trial NCT03663348?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03663348 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Takotsubo Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI